Back to search

United Kingdom· GB-APID-7323511000001108

Dacarbazine 500mg powder for solution for infusion vials

A dacarbazine product containing dacarbazine, registered in United Kingdom by medac UK. The same ATC class is registered in 15 of our 19 countries.

ATC L01AX04

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedDacarbazine 500mg powder for solution…ATCL01AX04REGISTER NO.GB-APID-7323511000001…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Dacarbazine is registered in 15 of 19 countries.

Countries holding a registration under ATC L01AX04 (dacarbazine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 8 of them publish a price we can compare per daily dose

Dacarbazine · ATC L01AX04

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dacarbazine costs, country by country.

Normalised to the WHO defined daily dose (43.3 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Dacarbazine · price per daily dose (43.3 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$5.12
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Dacarbazine
Manufacturer
medac UK
Country
United Kingdom (GB)
ATC code
L01AX04
ATC class
Dacarbazine
Defined daily dose
43.3 mg, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    4037353333338

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

237 interactions on record for dacarbazine.

Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Dacarbazine · interactions on record

237 records

  • 35 severe
  • 114 moderate
  • 14 minor
  • 74 info

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • Nalidixic acidJ01MB02severe
  • CladribineL01BB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dacarbazine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dacarbazine products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Dacarbazin Lipomed, Dacarbazine Medac
  • Belgium · Dacarbazine, Dacarbazine Medac
  • Cyprus · Dacarbazine Lipomed
  • Czechia · Dacarbazine Medac
  • Germany · Dacarbazin Lipomed, Detimedac
  • Denmark · Dacarbazine Lipomed, Dacarbazine Medac
  • Spain · Dacarbazina Accord, Dacarbazina Medac
  • Finland · Dacarbazine Lipomed, Dacarbazine Medac
  • France · Dacarbazine Accord, Dacarbazine Lipomed
  • Hungary · Dacarbazine Accord, Dacarbazine Lipomed
  • Ireland · Dacarbazine Lipomed, Dacarbazine Medac
  • Italy · Dacarbazina Lipomed, Dacarbazina Medac
  • Netherlands · Dacarbazine Medac
  • Norway · Dacarbazine Lipomed
  • Poland · Detimedac
  • Portugal · Dacarbazina Medac
  • Romania · Dacarbazina Lipomed
  • Sweden · Dacarbazine Medac
  • Slovakia · Dakarbazín Medac

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8237b6ba-9649-4c83-a9f7-bf77471cd149
GET /v1/drugs/8237b6ba-9649-4c83-a9f7-bf77471cd149?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "7323511000001108",
  "desc": "Dacarbazine 500mg powder for solution for infusion vials (medac UK)",
  "form": "Powder for solution for infusion",
  "vpid": "7322811000001103",
  "source": "dmd",
  "vtm_id": "775433001",
  "strength": "500 mg",
  "substance": "Dacarbazine",
  "ingredient": "Dacarbazine citrate",
  "supplier_code": "9241811000001108"
}

See everything about dacarbazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.